InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: None

Thursday, 01/31/2013 11:33:46 AM

Thursday, January 31, 2013 11:33:46 AM

Post# of 430218
Every new patent improves the likelihood that Vascepa's New Chemical Entity (NCE) status will be granted for a period of five years.

Obviously it increases the value of the company as a takeover target.

I'm still expecting a buyout in the $22.00 range sooner than most shareholders expect it to happen.

"Big pharma" is expected to spend almost $60,000,000,000 this year on mergers and acquisitions.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News